Descon Oxychem Limited (PSX:DOL)
Pakistan · Delayed Price · Currency is PKR 29.51
+0.23 (0.79%)
At close: Oct 15, 2026
Descon Oxychem Income Statement
Financials in millions PKR. Fiscal year is July - June.
Millions PKR. Fiscal year is Jul - Jun.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
| 5,114 | 5,999 | 5,738 | 6,721 | 4,250 | |
Revenue Growth | -14.75% | 4.54% | -14.63% | 58.13% | 51.54% |
Cost of Revenue | 4,135 | 4,242 | 4,584 | 3,965 | 3,149 |
Gross Profit | 978.5 | 1,757 | 1,154 | 2,756 | 1,102 |
Selling, General & Admin | 508.9 | 444.74 | 384.01 | 383.5 | 200.53 |
Other Operating Expenses | 83.61 | 98.86 | 64.62 | 156.24 | 51.31 |
Operating Expenses | 592.51 | 543.61 | 448.63 | 539.74 | 251.84 |
Operating Income | 385.99 | 1,213 | 705.48 | 2,217 | 849.96 |
Interest Expense | -58.43 | -3.62 | -15.97 | -11.77 | -47.78 |
Interest & Investment Income | 7.54 | 22.66 | 121.56 | 104.03 | 7.61 |
Currency Exchange Gain (Loss) | -4.23 | 14.23 | 4.17 | -78.88 | -15.2 |
Other Non Operating Income (Expenses) | 1.61 | 0.84 | 34.8 | -14.16 | -4.79 |
EBT Excluding Unusual Items | 332.48 | 1,247 | 850.04 | 2,216 | 789.81 |
Gain (Loss) on Sale of Investments | 62.29 | 61.85 | 4.16 | 7.68 | 0.73 |
Gain (Loss) on Sale of Assets | 0.02 | -0.08 | 0.06 | 0.11 | 0.06 |
Asset Writedown | -0.36 | - | - | - | - |
Other Unusual Items | 41.18 | - | - | - | 11.76 |
Pretax Income | 455.6 | 1,309 | 854.26 | 2,224 | 802.45 |
Income Tax Expense | 61.98 | 448.83 | 347.24 | 823.31 | 331.57 |
Net Income | 393.62 | 860.16 | 507.01 | 1,400 | 470.88 |
Net Income to Common | 393.62 | 860.16 | 507.01 | 1,400 | 470.88 |
Net Income Growth | -54.24% | 69.65% | -63.80% | 197.40% | 68.95% |
Shares Outstanding (Basic) | 175 | 175 | 175 | 175 | 175 |
Shares Outstanding (Diluted) | 175 | 175 | 175 | 175 | 175 |
Shares Change | - | - | - | - | - |
EPS (Basic) | 2.25 | 4.91 | 2.90 | 8.00 | 2.69 |
EPS (Diluted) | 2.25 | 4.91 | 2.90 | 8.00 | 2.69 |
EPS Growth | -54.24% | 69.65% | -63.80% | 197.40% | 68.95% |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Free Cash Flow | 63.97 | 1,425 | -124.69 | 1,653 | 678.77 |
Free Cash Flow Per Share | 0.36 | 8.14 | -0.71 | 9.45 | 3.88 |
Dividend Per Share | 4.000 | 4.000 | 2.000 | 4.000 | 2.000 |
Dividend Growth | 0% | 100.00% | -50.00% | 100.00% | 100.00% |
Gross Margin | 19.13% | 29.28% | 20.11% | 41.01% | 25.92% |
Operating Margin | 7.55% | 20.22% | 12.29% | 32.98% | 20.00% |
Profit Margin | 7.70% | 14.34% | 8.84% | 20.84% | 11.08% |
Free Cash Flow Margin | 1.25% | 23.76% | -2.17% | 24.60% | 15.97% |
EBITDA | 643.71 | 1,584 | 1,087 | 2,594 | 1,185 |
EBITDA Margin | 12.59% | 26.41% | 18.95% | 38.59% | 27.88% |
D&A For EBITDA | 257.72 | 371.11 | 381.91 | 377.3 | 334.92 |
EBIT | 385.99 | 1,213 | 705.48 | 2,217 | 849.96 |
EBIT Margin | 7.55% | 20.22% | 12.29% | 32.98% | 20.00% |
Effective Tax Rate | 13.61% | 34.29% | 40.65% | 37.02% | 41.32% |
Advertising Expenses | 17.52 | 20.35 | 17.93 | 10.81 | 0.05 |